Literature DB >> 23349024

Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4+ T cells.

Yukiko Iwasaki1, Keishi Fujio, Tomohisa Okamura, Atsushi Yanai, Shuji Sumitomo, Hirofumi Shoda, Tomohiko Tamura, Hiroki Yoshida, Patrick Charnay, Kazuhiko Yamamoto.   

Abstract

Interleukin-27 (IL-27) suppresses immune responses through inhibition of the development of IL-17 producing Th17 cells and induction of IL-10 production. We previously showed that forced expression of early growth response gene 2 (Egr-2), a transcription factor required for T-cell anergy induction, induces IL-10 and lymphocyte activation gene 3 expression and confers regulatory activity on CD4(+) T cells in vivo. Here, we evaluated the role of Egr-2 in IL-27-induced IL-10 production. Among various IL-10-inducing factors, only IL-27 induced high levels of Egr-2 and lymphocyte activation gene 3 expression. Intriguingly, IL-27 failed to induce IL-10 in Egr-2-deficient T cells. IL-27-mediated induction of Prdm1 that codes B lymphocyte induced maturation protein-1, a transcriptional regulator important for IL-10 production in CD4(+) T cells, was also impaired in the absence of Egr-2. Although IL-27-mediated IL-10 induction was dependent on both STAT1 and STAT3, only STAT3 was required for IL-27-mediated Egr-2 induction. These results suggest that IL-27 signal transduction through Egr-2 and B lymphocyte induced maturation protein-1 plays an important role in IL-10 production. Furthermore, Egr-2-deficient CD4(+) T cells showed dysregulated production of IFN-γ and IL-17 in response to IL-27 stimulation. Therefore, Egr-2 may play key roles in controlling the balance between regulatory and effector cytokines.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23349024     DOI: 10.1002/eji.201242942

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

1.  Eomesodermin promotes the development of type 1 regulatory T (TR1) cells.

Authors:  Ping Zhang; Jason S Lee; Kate H Gartlan; Iona S Schuster; Iain Comerford; Antiopi Varelias; Md Ashik Ullah; Slavica Vuckovic; Motoko Koyama; Rachel D Kuns; Kelly R Locke; Kirrilee J Beckett; Stuart D Olver; Luke D Samson; Marcela Montes de Oca; Fabian de Labastida Rivera; Andrew D Clouston; Gabrielle T Belz; Bruce R Blazar; Kelli P MacDonald; Shaun R McColl; Ranjeny Thomas; Christian R Engwerda; Mariapia A Degli-Esposti; Axel Kallies; Siok-Keen Tey; Geoffrey R Hill
Journal:  Sci Immunol       Date:  2017-04-07

Review 2.  Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance.

Authors:  Hanyu Zeng; Rong Zhang; Boquan Jin; Lihua Chen
Journal:  Cell Mol Immunol       Date:  2015-06-08       Impact factor: 11.530

3.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Prostaglandin E2 Inhibition of IL-27 Production in Murine Dendritic Cells: A Novel Mechanism That Involves IRF1.

Authors:  Kirsten M Hooper; Jui-Hung Yen; Weimin Kong; Kate M Rahbari; Ping-Chang Kuo; Ana M Gamero; Doina Ganea
Journal:  J Immunol       Date:  2017-01-06       Impact factor: 5.422

Review 5.  Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.

Authors:  Daniela Boehm; Melanie Ott
Journal:  AIDS Res Hum Retroviruses       Date:  2017-11       Impact factor: 2.205

Review 6.  Modulation of inflammation by interleukin-27.

Authors:  Markus Bosmann; Peter A Ward
Journal:  J Leukoc Biol       Date:  2013-07-31       Impact factor: 4.962

Review 7.  Regulatory T cells in autoimmune neuroinflammation.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

8.  Key role of macrophages in tolerance induction via T regulatory type 1 (Tr1) cells.

Authors:  B Mfarrej; T Jofra; C Morsiani; N Gagliani; G Fousteri; M Battaglia
Journal:  Clin Exp Immunol       Date:  2020-05-13       Impact factor: 4.330

Review 9.  IL-27-induced modulation of autoimmunity and its therapeutic potential.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Steven Dudics; Bodhraj Acharya; Kamal D Moudgil
Journal:  Autoimmun Rev       Date:  2015-08-05       Impact factor: 9.754

Review 10.  Therapeutic potential of regulatory cytokines that target B cells.

Authors:  Keishi Fujio; Tomohisa Okamura; Shuji Sumitomo; Kazuhiko Yamamoto
Journal:  Int Immunol       Date:  2015-12-08       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.